Imedex E-learning (audio)

Joel R. Rosh, MD, FACG: Counterpoint: Clinical remission is all that matters while dealing with the new biologic therapy

Informações:

Sinopsis

Webcast: Great Debates and Updates in Inflammatory Bowel Disease 2018